Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rhinoconjunctivitis, Allergic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00574210
What this trial is testing

PK/PD and Steady State Efficacy Study of Bilastine Compared With Placebo Given Orally in the Treatment of the Symptoms of SAR in an EEC Model (5-arm)

Who this might be right for
Seasonal Allergic RhinitisHay FeverRhinoconjunctivitis
Faes Farma, S.A. 502
Early research (Phase 1)Study completedNCT00813046
What this trial is testing

Safety and Tolerance Study of Grass Pollen-derived Peptides to Treat Allergic Rhinitis

Who this might be right for
Seasonal Allergic Rhinoconjunctivitis
BioTech Tools S.A. 8
Not applicableStudy completedNCT04532762
What this trial is testing

Demonstration of a Decongestant Effect of "Coldamaris Akut" Compared to Saline Nasal Spray.

Who this might be right for
Allergic RhinitisAllergic Rhinoconjunctivitis
Marinomed Biotech AG 42
Early research (Phase 1)Study completedNCT01707069
What this trial is testing

A Safety and Immunogenicity Phase I Study of CryJ2-DNA-Lysosomal Associated Membrane Protein (CryJ2 -DNA-LAMP) Plasmid

Who this might be right for
Allergic Rhinoconjunctivitis
Immunomic Therapeutics, Inc. 24
Early research (Phase 1)Study completedNCT03931993
What this trial is testing

Tolerability and Safety of a New Cumulative Dose of Grass MATA MPL

Who this might be right for
Seasonal Allergic Rhinitis
Allergy Therapeutics 30
Testing effectiveness (Phase 2)Study completedNCT01564017
What this trial is testing

Dose-response Study With Subcutaneous Immunotherapy of an Standardized Dermatophagoides Pteronyssinus (DPT) Extract

Who this might be right for
Allergic Rhinoconjunctivitis
Roxall Medicina España S.A 150
Testing effectiveness (Phase 2)Study completedNCT00777374
What this trial is testing

Study of Specific Allergen Immunotherapy in Grass Pollen Allergic Subjects With Epicutanoeus Allergen Administration

Who this might be right for
Allergic Rhinoconjunctivitis
University of Zurich 97
Large-scale testing (Phase 3)Study completedNCT00504933
What this trial is testing

Efficacy Study for the Symptomatic Treatment of Seasonal Allergic Rhinitis

Who this might be right for
Seasonal Allergic Rhinitis
Faes Farma, S.A. 683
Early research (Phase 1)Study completedNCT00889460
What this trial is testing

Safety and Tolerability Study of rBet v1 SLIT Tablets

Who this might be right for
Birch Pollen-Related RhinoconjunctivitisRhinitis, Allergic, Seasonal
Stallergenes Greer 55
Large-scale testing (Phase 3)Looking for participantsNCT04891237
What this trial is testing

Efficacy and Safety Evaluation for the Treatment of Allergy Against Grass and Olive Pollen

Who this might be right for
Rhinitis, AllergicRhinoconjunctivitisAsthma, Allergic
Inmunotek S.L. 180
Testing effectiveness (Phase 2)Study completedNCT01466465
What this trial is testing

Vitamin D and Grass Pollen Specific Immunotherapy

Who this might be right for
Allergic Rhinoconjunctivitis
Charite University, Berlin, Germany 35
Large-scale testing (Phase 3)Looking for participantsNCT04898283
What this trial is testing

Efficacy and Safety Evaluation of the Treatment of Allergy Against Cupressaceae and Grasses.

Who this might be right for
Rhinitis, AllergicRhinoconjunctivitisAsthma, Allergic
Inmunotek S.L. 180
Testing effectiveness (Phase 2)Study completedNCT01033344
What this trial is testing

Cat-PAD Exposure Chamber Study

Who this might be right for
Cat Allergy
Circassia Limited 210
Testing effectiveness (Phase 2)Study completedNCT00901914
What this trial is testing

Study of rBet v1 Tablets

Who this might be right for
Birch Pollen-related RhinoconjunctivitisRhinitis, Allergic, Seasonal
Stallergenes Greer 483
Testing effectiveness (Phase 2)Study completedNCT02061709
What this trial is testing

Evaluating the Efficacy of Ragweed-SPIRE Following Exposure to Ragweed Allergen in an Environmental Exposure Chamber

Who this might be right for
Seasonal Allergic Rhinitis
Circassia Limited 280
Large-scale testing (Phase 3)Study completedNCT01620762
What this trial is testing

Phase III Cat-PAD Study

Who this might be right for
Rhinoconjunctivitis
Circassia Limited 1,408
Not applicableStudy completedNCT02844842
What this trial is testing

Evaluation of Tolerability and Safety of "Allergovac Poliplus" in Polysensitized Patients With Rhinitis or Allergic Rhinoconjunctivitis With or Without Asthma: A Study in Daily Clinical Practice

Who this might be right for
Allergic RhinitisRhinoconjunctivitisAsthma
Roxall Medicina España S.A 152
Testing effectiveness (Phase 2)Study completedNCT02556801
What this trial is testing

Efficacy and Safety of SUBLIVAC Phleum for Immunotherapy of Grass Pollen-Allergy

Who this might be right for
Allergic RhinitisAllergic Rhinoconjunctivitis
HAL Allergy 168
Early research (Phase 1)Study completedNCT00396149
What this trial is testing

Safety, Tolerability and Pharmacodynamic Effects of Sublingual Immunotherapy (Tablets) With Recombinant Bet v1

Who this might be right for
Birch Pollen-Related RhinoconjunctivitisRhinitis, Allergic, Seasonal
Stallergenes Greer 57
Not applicableStudy completedNCT04583202
What this trial is testing

Evaluation of the Nasal and Conjunctival Response in Subjects Allergic to Birch Pollen in the ALYATEC Environmental Exposure Chamber

Who this might be right for
Allergic RhinitisAllergy to PollenRhinoconjunctivitis
Alyatec 30
Next Page